Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

PMDA recommends additional trial for Chugai's new Epogin injection indication

Oct. 1, 2007

Patient dosing begins in DiObex's phase IIb trial of type 2 diabetes drug

Oct. 1, 2007

Positive results for Orexigen's two phase I trials of naltrexone SR

Oct. 1, 2007

Similar efficacy seen with ibandronate and alendronate in postmenopausal osteoporosis

Oct. 1, 2007

Recent patents describe new treatment options for endocrine-related disorders

Sep. 28, 2007

Update on Pipex's development of oral Coprexa for Wilson's disease

Sep. 28, 2007

Velcura reports pre-IND meeting with FDA for VEL-0230 for bone disease

Sep. 28, 2007

Nastech initiates phase II clinical trial for insulin nasal spray

Sep. 28, 2007

Strontium malonate offers better bioavailability than strontium ranelate

Sep. 28, 2007

Diabetes snapshots: new data on GLP-1 receptor agonists

Sep. 28, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...